Skip to content
Search

Latest Stories

Coronavirus cases in UK rise to 85 in biggest daily jump

pharmacy.biz Staff
By pharmacy.biz StaffMar 04, 2020
pharmacy.biz Staff
See Full Bio

The number of confirmed coronavirus cases in the UK rose to 85 on Wednesday in the biggest daily jump since it was first detected in the country, health ministry figures showed on Wednesday.

"As of 9 am this morning 32 further patients in England have tested positive for COVID-19," said Professor Chris Whitty, Cheif Medical Officer for England.

The number of confirmed cases was 51 on Tuesday.

"Three additional patients contracted the virus in the UK and it is not yet clear whether they contracted it directly or indirectly from an individual who had recently returned from abroad. This is being investigated and contact tracing has begun," Whitty said.

"The total number of confirmed cases in England is now 80. Following previously reported confirmed cases in Northern Ireland, Wales and Scotland, the total number of UK cases is 85."

(With Reuters inputs)

Related News

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK
News

Aspire acquires UK distribution rights from Tetris

GP surgery upgrades for annual appointments
News

GP surgery upgrades to create 8.3 million more annual appointments

Empowering women in pharmacy through self-advocacy
Guest Blog

Advocate for yourself – Celebrating International Women’s Day

It is official: Opella is now a standalone company
News

Opella becomes standalone company as Sanofi-CD&R deal closes

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Pharmacist declining participation in assisted dying under new UK legislation

It could take another four years for assisted dying to become law

Pic credit: iStock

Pharmacists to have choice to opt-out of assisted dying process

Pharmacists will not be forced to be a part in assisted dying cases with the MP leading the campaign expected to made amendments to the bill which is currently going through parliamentary process.

Kim Leadbeater, the MP behind the Terminally Ill Adults (End of Life) Bill, will say that “no person is under any duty to participate in the provision of assistance”.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc